318 related articles for article (PubMed ID: 17179392)
1. Glucose intolerance and reduced islet blood flow in transgenic mice expressing the FRK tyrosine kinase under the control of the rat insulin promoter.
Annerén C; Welsh M; Jansson L
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1183-90. PubMed ID: 17179392
[TBL] [Abstract][Full Text] [Related]
2. Increased cytokine-induced cytotoxicity of pancreatic islet cells from transgenic mice expressing the Src-like tyrosine kinase GTK.
Annerén C; Welsh M
Mol Med; 2001 May; 7(5):301-10. PubMed ID: 11474576
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice expressing Shb adaptor protein under the control of rat insulin promoter exhibit altered viability of pancreatic islet cells.
Welsh M; Christmansson L; Karlsson T; Sandler S; Welsh N
Mol Med; 1999 Mar; 5(3):169-80. PubMed ID: 10404514
[TBL] [Abstract][Full Text] [Related]
4. Glucose homeostasis, insulin secretion, and islet phospholipids in mice that overexpress iPLA2beta in pancreatic beta-cells and in iPLA2beta-null mice.
Bao S; Jacobson DA; Wohltmann M; Bohrer A; Jin W; Philipson LH; Turk J
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E217-29. PubMed ID: 17895289
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice.
Guo Y; Lu Y; Houle D; Robertson K; Tang Z; Kopchick JJ; Liu YL; Liu JL
Endocrinology; 2005 Jun; 146(6):2602-9. PubMed ID: 15731363
[TBL] [Abstract][Full Text] [Related]
6. Transgenic overexpression of active calcineurin in beta-cells results in decreased beta-cell mass and hyperglycemia.
Bernal-Mizrachi E; Cras-Méneur C; Ye BR; Johnson JD; Permutt MA
PLoS One; 2010 Aug; 5(8):e11969. PubMed ID: 20689817
[TBL] [Abstract][Full Text] [Related]
7. Analysis of rat insulin II promoter-ghrelin transgenic mice and rat glucagon promoter-ghrelin transgenic mice.
Iwakura H; Hosoda K; Son C; Fujikura J; Tomita T; Noguchi M; Ariyasu H; Takaya K; Masuzaki H; Ogawa Y; Hayashi T; Inoue G; Akamizu T; Hosoda H; Kojima M; Itoh H; Toyokuni S; Kangawa K; Nakao K
J Biol Chem; 2005 Apr; 280(15):15247-56. PubMed ID: 15701644
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Pref-1 in pancreatic islet β-cells in mice causes hyperinsulinemia with increased islet mass and insulin secretion.
Wang Y; Lee K; Moon YS; Ahmadian M; Kim KH; Roder K; Kang C; Sul HS
Biochem Biophys Res Commun; 2015 Jun; 461(4):630-5. PubMed ID: 25918019
[TBL] [Abstract][Full Text] [Related]
9. The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity.
Welsh M; Welsh C; Ekman M; Dixelius J; Hägerkvist R; Annerén C; Akerblom B; Mahboobi S; Chandrasekharan S; Liu ET
Biochem J; 2004 Aug; 382(Pt 1):261-8. PubMed ID: 15186217
[TBL] [Abstract][Full Text] [Related]
10. A role of FRK in regulation of embryonal pancreatic beta cell formation.
Akerblom B; Annerén C; Welsh M
Mol Cell Endocrinol; 2007 May; 270(1-2):73-8. PubMed ID: 17416457
[TBL] [Abstract][Full Text] [Related]
11. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
[TBL] [Abstract][Full Text] [Related]
12. Altered islet morphology but normal islet secretory function in vitro in a mouse model with microvascular alterations in the pancreas.
Kostromina E; Wang X; Han W
PLoS One; 2013; 8(7):e71277. PubMed ID: 23923060
[TBL] [Abstract][Full Text] [Related]
13. Constitutively active stimulatory G-protein alpha s in beta-cells of transgenic mice causes counterregulation of the increased adenosine 3',5'-monophosphate and insulin secretion.
Ma YH; Landis C; Tchao N; Wang J; Rodd G; Hanahan D; Bourne HR; Grodsky GM
Endocrinology; 1994 Jan; 134(1):42-7. PubMed ID: 7506212
[TBL] [Abstract][Full Text] [Related]
14. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice.
García-Ocaña A; Vasavada RC; Cebrian A; Reddy V; Takane KK; López-Talavera JC; Stewart AF
Diabetes; 2001 Dec; 50(12):2752-62. PubMed ID: 11723058
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice.
Cantley J; Choudhury AI; Asare-Anane H; Selman C; Lingard S; Heffron H; Herrera P; Persaud SJ; Withers DJ
Diabetologia; 2007 Jun; 50(6):1248-56. PubMed ID: 17393136
[TBL] [Abstract][Full Text] [Related]
16. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.
Annerén C; Welsh M
Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087
[TBL] [Abstract][Full Text] [Related]
17. Glucose intolerance and impaired insulin secretion in pancreas-specific signal transducer and activator of transcription-3 knockout mice are associated with microvascular alterations in the pancreas.
Kostromina E; Gustavsson N; Wang X; Lim CY; Radda GK; Li C; Han W
Endocrinology; 2010 May; 151(5):2050-9. PubMed ID: 20215569
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F
J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441
[TBL] [Abstract][Full Text] [Related]
19. CART decreases islet blood flow, but has no effect on total pancreatic blood flow and glucose tolerance in anesthetized rats.
Drott CJ; Norman D; Espes D
Peptides; 2021 Jan; 135():170431. PubMed ID: 33098940
[TBL] [Abstract][Full Text] [Related]
20. Chronic sympathetic innervation of islets in transgenic mice results in differential desensitization of alpha-adrenergic inhibition of insulin secretion.
Grodsky GM; Ma YH; Edwards RH
Adv Exp Med Biol; 1997; 426():129-38. PubMed ID: 9544265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
